可比特雾化吸入治疗慢性阻塞性肺病疗效观察及护理

Study on Effect of Kebite Jet Nebulizer Inhalation on COPD and Nursing

目的观察可比特雾化吸入剂对慢性阻塞性肺病的治疗作用。方法将50例病人随机分为2组。对照组应用抗炎、祛痰、平喘治疗;治疗组在对照组的基础上加用可比特雾化剂雾化吸入5～7天,治疗前与治疗后分别观察肺功能与显效率。结果两组治疗5～7天后,治疗组的显效率、有效率明显高于对照组,差异有显著性(P<0．05)。治疗组:肺功能指标FEV1由治疗前的1．0±0．51到治疗后的1．47±0．60,PEF由治疗前的2．9±1．01到治疗后的4．32±1．08,差异有高度显著性(P<0． 01),而对照功能指标FEV1由治疗前的1．03±0．28到治疗后的1．22±0．3,PEF由治疗前的3．03±1．10到治疗后的3．75±1． 20,差异有显著性(P<0．05),两组间肺功能指标比较治疗组明显优于对照组(P<0．05)。结论可比特雾化剂客化吸入提高慢性阻塞性肺病的疗效,改善病人的肺功能。

Objective To study the effect of Kebite jet nebulizer inhalation on COPD. Methods 50 cases were randomly divided into two groups. The control group was given anti inflammatory therapy and pectoral and antiasthmoid treatment. While the treatment group was given kebite jet nebulizer inhalation additionally for 5 - 7 days on the basis of the control group, observing the pulmonary functions and the regreession rate. Results After 5 - 7 days treatment, the regression rate and effective rate of the treatment group were much higher than that of the control group（ P 〈 0.05）. For the treatment group, the pulmonary function index FEV1 changed from 1. 0 ± 0.51 before the treatment to 1.47 ± 0.60 after the treatment, PEF from 2.9 ± 1.01 to 4.32 ± 1.08. There was significant difference （P〈0.01）. However, in the control group, the pulmonary function index FEV1 changed from 1.03 ± 0.28 before the treatment to 1.22 ± 0.3 after the treatment, PEF from 3.03 ± 1.10 to 3.75 ±1.20, there was difference （P〈0.05）. The treatment group was much better than that of the control group in the pulmonary function index （P〈0.05）. Conclusion Kebite jet nebulizer inhalation can improve the effect of COPD and the patients＇ pulmonary function.